Molecular Formula | C30H30FN7O6 |
Molar Mass | 603.6009032 |
Solubility | DMSO: ≥300 mg/mL |
Storage Condition | -20℃ |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.657 ml | 8.284 ml | 16.567 ml |
5 mM | 0.331 ml | 1.657 ml | 3.313 ml |
10 mM | 0.166 ml | 0.828 ml | 1.657 ml |
5 mM | 0.033 ml | 0.166 ml | 0.331 ml |
use | N-(3-(2-((3-fluoro-4-(4-methylpiperazine-1-yl) phenyl) amino)-7H-pyrrolo [2,3-D] pyrimidin-4-yl) oxyl) phenyl) acrylamide salt is avitinib maleate. Avitinib maleate is a domestic third-generation EGFR-TKI. Usually, avitinib is made into pharmaceutically acceptable salts such as avitinib maleate, avitinib mesylate, avitinib tartrate and other preparations for oral treatment of lung cancer patients. |